ADARx Pharmaceuticals, Inc.

ADRX·NasdaqGS·Healthcare
Compare
13.23−0.06 (−0.45%)today
At close: Nov 6, 4:00 PM EST · May be delayed up to 15 min · USD
After hours13.230.00 (0.00%)Nov 6, 4:00 PM EST

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close13.29
Open13.73
Day range12.5013.73
52-week range12.5023.21
Off day high−3.64%
Off 52-week high−43.00%
Volume439.98K
Avg. volume (3M)673.75K
Market cap1.47B
EPS (TTM)-1.16
Forward P/E-8.74
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding110.74M
Short interest—
Earnings date—
Analyst target34.25
Profit margin0.00%

Against its peers

Compare in full ›
ADRX GPCR ALEC 2257.HK ARWR PRTA
Market cap 1.47B 1.45B 255.69M 464.26M 8.22B 409.26M
P/E (TTM) — — — — — —
Forward P/E -8.7 -9.6 -3.1 — -11.7 -6.1
Price/book -0.6 1.1 2.2 -9.5 17.6 1.5
Dividend yield — — — — — —
1-year change −31.32% −39.97% +63.28% −46.68% +45.95% −24.31%
Today −0.45% +6.66% +9.57% −0.12% +1.22% +1.01%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ADRX news ›
Markets Daily·Positive

AdvanSix (ASIX) To Go Ex-Dividend on November 17th

Posted by Tristan Rich on Nov 6th, 2026 AdvanSix has a payout ratio of 16.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect AdvanSix to earn $1.95 per share next year, which means the company should…

Defense World·Positive

ADARx Pharmaceuticals (NASDAQ:ADRX) Upgraded at Zacks Research

Zacks Research upgraded shares of ADARx Pharmaceuticals (NASDAQ:ADRX – Free Report) to a hold rating in a research note published on Wednesday morning,Zacks reports. ADRX has been the topic of several other reports. Wall Street Zen raised…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
6with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance